Izon
1 known investors
Izon develops single-particle characterisation and nanoparticle purification technologies, including Nanopore Pulse Sensing/TRPS instruments (Pulsoid, Exoid) and size exclusion chromatography-based qEV isolation columns and bioprocessing systems. Its products serve researchers and developers working on extracellular vesicles, lipid nanoparticles, and other nanoparticles for diagnostic, therapeutic, and cosmetic development.